Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Trovagene Inc (TROV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014320
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc (TROV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Trovagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Trovagene Inc, Medical Devices Deals, 2011 to YTD 2017 9
Trovagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Trovagene Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 11
Licensing Agreements 13
Trovagene Enters into Licensing Agreement with Nerviano Medical Sciences for PCM-075 13
Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 14
Trovagene Enters Into Licensing Agreement With Genoptix For NPM1 Marker 15
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 16
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 17
Trovagene Inc – Key Competitors 18
Trovagene Inc – Key Employees 19
Trovagene Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results 21
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 23
Corporate Communications 25
Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 25
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 26
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Trovagene Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Trovagene Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Trovagene Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Trovagene Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Trovagene Inc, Medical Devices Deals, 2011 to YTD 2017 9
Trovagene Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 11
Trovagene Enters into Licensing Agreement with Nerviano Medical Sciences for PCM-075 13
Trovagene Enters Into Licensing Agreement With Duke University And Duke University Health Systems For NPM1 Marker 14
Trovagene Enters Into Licensing Agreement With Genoptix For NPM1 Marker 15
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 16
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 17
Trovagene Inc, Key Competitors 18
Trovagene Inc, Key Employees 19
Trovagene Inc, Subsidiaries 20

★海外企業調査レポート[Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korber AG:戦略・SWOT・企業財務分析
    Korber AG - Strategy, SWOT and Corporate Finance Report Summary Korber AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Allightsykes Pty Ltd:企業の戦略・SWOT・財務分析
    Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Taiheiyo Cement Corporation
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bio-Alternative Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Bio-Alternative Medical Devices Ltd (Bio AMD), a subsidiary of Bio-AMD Inc, is a medical device company that designs, develops, and markets point of care medical diagnostic products. The company offers products such as blood coagulation monitor, digital strip reader, and magnetic immunoassay …
  • United States Cellular Corp (USM):企業の財務・戦略的SWOT分析
    United States Cellular Corp (USM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CytoSorbents Corp (CTSO)-製薬・医療分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • OP Financial Group:企業の戦略・SWOT・財務分析
    OP Financial Group - Strategy, SWOT and Corporate Finance Report Summary OP Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Power Assets Holdings Limited (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Dermala Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermala Inc (Dermala) is a healthcare products manufacturer that offers skin care products. The company offers acne treatment products such as zinc, acne spot treatment, acne pimple patches, advanced probiotics, acne treatment pads, and acne treatment system. It uses the human microbiome and …
  • PanAtlantic Exploration Co:企業の戦略的SWOT分析
    PanAtlantic Exploration Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kiwibank Limited:企業の戦略・SWOT・財務情報
    Kiwibank Limited - Strategy, SWOT and Corporate Finance Report Summary Kiwibank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dubai Electricity and Water Authority:電力:M&Aディール及び事業提携情報
    Summary Dubai Electricity and Water Authority (DEWA) is an electricity and water utility. It generates, transmits and distributes electricity; and desalinates water. The authority produces electricity using gas and steam turbines, and solar PV plants. DEWA’s plants include Jebel Ali Station D, E and …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Global Petroleum Ltd (GBP):企業の財務・戦略的SWOT分析
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. It operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan de Nova …
  • Rum Group for Transportation & Tourism Investment:企業の戦略・SWOT・財務情報
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company provides DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages, among others. It provides solutions in genomics research …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆